ClearNote Health’s VP Translational Research & Head of Biopharma Development, Gulfem D. Guler, and Senior Scientist-Translational Research, Ceyda Coruh, are attending the 9th Liquid Biopsy for Precision Oncology Summit February 18-20, San Diego.

Connect to learn more about ClearNote Health’s Virtuoso Epigenomics Platform. Virtuoso leverages 5hmC epigenomic profiling to uncover active cancer biology patterns from cfDNA in plasma, empowering more efficient oncology drug discovery and development.